Clinical Risk Prediction Model for Neoadjuvant Therapy in Resectable Esophageal Adenocarcinoma
Conclusions:
We constructed a nomogram to facilitate an individualized prediction of the risk of locally advanced EAC. This model can aid in decision making for neoadjuvant therapy in EAC.
Source: Journal of Clinical Gastroenterology - Category: Gastroenterology Tags: Alimentary Tract: Original Articles Source Type: research
More News: Adenocarcinoma | Bleeding | Esophagus Cancer | Gastroenterology | Neoadjuvant Therapy | PET Scan | Study | Ultrasound | Weight Loss